TrialLiver international : official journal of the International Association for the Study of the Liver2020

Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies.

Betty B Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.